New cancer clinical trial: M7824 in Consensus Molecular Subtype 4, Treatment-Refractory Metastatic Colorectal Cancer

Published on: February 16, 2018 at 12:00PM
Conditions:   Adenocarcinoma of the Colon;   Adenocarcinoma of the Rectum
Intervention:   Drug: M7824
Sponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.;   EMD Serono
Not yet recruiting
http://ift.tt/2HvhBuT